Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease - Guideline Learning Activities - Guideline Central

Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

American Gastroenterological Association

Publication Date: May 27, 2021

The Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease guideline, developed by the American Gastroenterological Association, provides evidence-based recommendations for the outpatient medical management of moderate to severe luminal and fistulizing Crohn’s disease (CD).
10
Questions
12
Minutes Est.
200
Possible Points
Unrated
Difficulty
Objectives
  • Recognizing medications used for remission induction in moderate to severe Crohn’s disease
  • Learning management of secondary nonresponse in moderate to severe Crohn’s disease
  • Identifying anti-TNFα use in moderate to severe Crohn’s disease
  • Understanding biologic monotherapy in moderate to severe Crohn’s disease
  • Recognizing infliximab use in moderate to severe Crohn’s disease
Instructions
Answer All QuestionsYou must answer each question to move forward.
Get Instant FeedbackAfter you submit each answer, you'll receive an explanation.
Progress is Saved AutomaticallyYour progress is saved as you go, so you can stop and return to the quiz anytime.
Compare Your ResultsSee how your performance compares with your peers after each answer is submitted.
Earn PointsPoints are awarded for each correct answer.
Members Only FeaturesIf you're a member, you can track your progress and view the quizzes you've completed.
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.